Schedule 13D ownership disclosure

PERNIX THERAPEUTICS HOLDINGS, INC.

Security class unavailable · CUSIP: 71426V108

Event date: 2015-08-06

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
183,959
Percent of class
0.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-15-059082
Form type
SC 13D/A
Filer
Cetus Capital II, LLC
CIK
CIK 1561987
Filed
Aug 12, 2015
Reporting period
Aug 06, 2015
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub